Please login first

Vaccines Webinar | Infection and (Presymptomatic) Transmission of SARS-CoV-2

04/12/2020 00:00

Vaccines, Infection, Presympomatic, SARS-CoV-2, Presymptomatic
Add this event to bookmarks
Contact Us

Webinar Information

1st Vaccines Webinar

Infection and (Presymptomatic) Transmission of SARS-CoV-2

SARS-CoV-2 is the newly identified human coronavirus that emerged in December 2019, resulting in severe respiratory disease and viral pneumonia. The disease was later named COVID-19 and has resulted in thousands of deaths to date. Research is underway to understand the transmission and pathogenicity, and to develop treatments and preventative measures for this serious illness. This webinar will discuss the latest advances in understanding the spread of SARS-CoV-2 and its pathogenicity, and will highlight the progress in vaccine and antiviral drug development.

Date: 4 December 2020

Time: 2pm (CET) | 8am (EDT) | 9pm (CST Asia)

Webinar ID: 868 8022 2663

Chair: Dr. Hatem Elshabrawy

Webinar Secretariat: [email protected]

This webinar will include the following experts:

Dr. Hatem Elshabrawy

Affiliation: Assistant Professor at Sam Houston State University, College of Osteopathic Medicine

Interests: Development of antiviral small molecules and antibodies


Guest Editor of “Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19”


Dr. Francesco De Sanctis

Affiliation: Università degli Studi di Verona, Sez.Immunologia, Dipartimento di Medicina, Policlinico G.B. Rossi, Italy

Interests: immunology; cancer immunology; cancer immunotherapy; tumor microenvironment; TILs; adoptive cell therapy; T cells; tumor immunosuppression; MDSCs; tumor vaccination

Prof. Maria Anagnostouli

Affiliation: Neurology Demyelinating Diseases Unit & Director of Immunogenetics Laboratory, 1st Department of Neurology of the Medical School, National and Kapodistrian University of Athens, Athens, Greece

Interests: clinical immunology; immunogenetics; neurology; multiple sclerosis; demyelinating diseases; autoimmunity

Dr. Hussin Rothan

Affiliation: Department of Biology, College of Arts and Sciences, Georgia State University, Atlanta, GA 30302 USA

Interests: flavivirus; alphaviris; vaccines; nanoparticles; antibody responses

Dr. Kathleen L. Hefferon

Affiliation: Department of Cell and Systems Biology, University of Toronto, St. George Campus, 25 Willcocks Street, Toronto, ON M5S3B2, Canada

Interests: vaccines; plant viruses; virus expression vectors; tobacco mosaic virus; potato virus X; cowpea mosaic virus; nanoparticles

Program

The webinar will start at 2:00 pm (CET) and will last maximum 2 hours.

Presentation

Time CET

Time EDT

Time CST

Dr. Hatem Elshabrawy

Introduction

2:00pm

8:00am

9:00pm

Dr. Francesco De Sanctis

"Deciphering the state of immune silence in fatal COVID-19 patients"

2:05pm

8:05am

9:05pm

Q&A

2:25pm

8.25am

9:25pm

Prof. Maria Anagnostouli

"Host HLA-genotype and COVID-19 infection. Impact on severity, clinical outcome and therapeutics "

2:30pm

8:30am

9:30pm

Q&A

2:50pm

8:50am

9:50pm

Dr. Hussin Rothan:

"The widespread of SARS-CoV-2 virus could be attributed to the genetic variation in the viral spikes "

2:55pm

8:55am

9:55pm

Q&A

3:15pm

9:15am

10:15pm

Dr. Kathleen L. Hefferon:

"Using Plants to Fight COVID-19"

3:20pm

9:20am

10:20pm

Q&A

3:40pm

9:40am

10:40pm

Concluding remarks

3:45pm

9:45am

10:45pm

Webinar Content

The first Vaccines webinar was organised on 4 December 2020. The online seminar was chaired by Dr. Hatem Elshabrawy, Assistant Professor at Sam Houston State University.

The first presentation was given by Dr. Francesco De Sanctis, from University of Verona. He talked about deciphering the state of immune silence in fatal COVID-19 patients. He was followed by Prof. Dr. Maria Anagnostouli, from National and Kapodistrian University of Athens. Her talk was on the Host HLA-genotype and COVID-10 infection and its impact on severity, clinical outcome and therapeutics.

Dr. Hussin Rothan from Georgia State University was the third presenter and discussed how the widespread of SARS-CoV-2 virus could be attributed to the genetic variation in the viral spikes. The fourth and final presentation was given by Dr. Kathleen Hefferon from University of Toronto. She presented a different approach – that of using plants to fight COVID-19.

Each presentation was followed by a short Q&A, where the presenters answered the questions from the attendees. The webinar was offered via Zoom and required registration to attend. The full recording can be found below. In order to stay updated on the next webinars on Vaccines, be sure to sign up for our newsletter by clicking on “Subscribe” at the top of the page.

Relevant Special Issue

Unraveling SARS-CoV-2 Pathogenesis: Development of Vaccines and Therapeutics for COVID-19
Guest Editor: Dr. Hatem A. Elshabrawy
Deadline for manuscript submissions:31 December 2020

Sponsors and Partners

Organizers

Top